PL2723385T3 - Kompozycja błonotwórcza i jej zastosowanie do leczenia opryszczki - Google Patents

Kompozycja błonotwórcza i jej zastosowanie do leczenia opryszczki

Info

Publication number
PL2723385T3
PL2723385T3 PL12731592T PL12731592T PL2723385T3 PL 2723385 T3 PL2723385 T3 PL 2723385T3 PL 12731592 T PL12731592 T PL 12731592T PL 12731592 T PL12731592 T PL 12731592T PL 2723385 T3 PL2723385 T3 PL 2723385T3
Authority
PL
Poland
Prior art keywords
film
forming composition
treating herpes
herpes
treating
Prior art date
Application number
PL12731592T
Other languages
English (en)
Inventor
Nathalie DERAIN
Original Assignee
Urgo Recherche Innovation Et Développement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Recherche Innovation Et Développement filed Critical Urgo Recherche Innovation Et Développement
Publication of PL2723385T3 publication Critical patent/PL2723385T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12731592T 2011-06-22 2012-06-21 Kompozycja błonotwórcza i jej zastosowanie do leczenia opryszczki PL2723385T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1155493A FR2976808B1 (fr) 2011-06-22 2011-06-22 Composition filmogene et son utilisation pour le traitement de l'herpes
PCT/FR2012/051417 WO2012175879A1 (fr) 2011-06-22 2012-06-21 Composition filmogène et son utilisation pour le traitement de l'herpès
EP12731592.7A EP2723385B1 (fr) 2011-06-22 2012-06-21 Composition filmogène et son utilisation pour le traitement de l'herpès

Publications (1)

Publication Number Publication Date
PL2723385T3 true PL2723385T3 (pl) 2020-03-31

Family

ID=46456911

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12731592T PL2723385T3 (pl) 2011-06-22 2012-06-21 Kompozycja błonotwórcza i jej zastosowanie do leczenia opryszczki

Country Status (17)

Country Link
US (1) US9226989B2 (pl)
EP (1) EP2723385B1 (pl)
JP (1) JP2014517060A (pl)
KR (1) KR101898635B1 (pl)
CN (1) CN103796682B (pl)
AU (1) AU2012273819A1 (pl)
BR (1) BR112013033145B1 (pl)
CA (1) CA2839473C (pl)
ES (1) ES2751100T3 (pl)
FR (1) FR2976808B1 (pl)
LT (1) LT2723385T (pl)
MX (1) MX338724B (pl)
PL (1) PL2723385T3 (pl)
PT (1) PT2723385T (pl)
RU (1) RU2578959C2 (pl)
WO (1) WO2012175879A1 (pl)
ZA (1) ZA201309630B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11491255B2 (en) 2015-04-06 2022-11-08 3M Innovative Properties Company Removable film forming gel compositions and methods for their application
CN107320766A (zh) * 2016-12-08 2017-11-07 沈阳圣劳伦斯医疗器械有限公司 一种用于皮肤浅表创面保护的组合物
WO2022133629A1 (zh) * 2020-12-21 2022-06-30 江苏奇力康皮肤药业有限公司 一种喷雾型液体创可贴及其制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285934A (en) * 1979-07-13 1981-08-25 Tinnell James E Treatment for herpes virus
US4374126A (en) * 1981-02-23 1983-02-15 Warner-Lambert Company Film forming antimicrobial material
US4783335A (en) * 1985-11-18 1988-11-08 The Kendall Company Controlled topical application of bioactive reagent
EP0289900A1 (en) 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions
WO1989010745A1 (en) * 1988-05-02 1989-11-16 Pomerantz, Edwin Compositions and in situ methods for forming films on body tissue
US5081158A (en) 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
US5547662A (en) * 1993-08-27 1996-08-20 Becton, Dickinson And Company Preparation of a skin surface for a surgical procedure
SK281575B6 (sk) * 1994-03-21 2001-05-10 Thomsen John Brown Farmaceutický prostriedok vo forme gélu na liečbu kožných ochorení
GB9408545D0 (en) 1994-04-29 1994-06-22 Zyma Sa Compositions
US5906814A (en) * 1995-12-07 1999-05-25 The Andrew Jergens Company Topical film-forming compositions
WO1997025018A1 (en) * 1996-01-11 1997-07-17 Launceston, Ltd. Scented nail polish
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
FR2783832A1 (fr) * 1998-09-30 2000-03-31 Warner Lambert Co Compositions de film d'amidon modifie
KR100601408B1 (ko) * 1998-09-30 2006-07-14 워너-램버트 캄파니 엘엘씨 개질 전분 필름 조성물
JP4065691B2 (ja) * 1999-07-22 2008-03-26 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー プルラン膜組成物
MD1779G2 (ro) * 2001-06-29 2002-05-31 Молдо-франко-румынское совместное предприятие "ЕУРОФАРМ" с ограниченной ответственностью Compoziţie dermatologică peliculogenă cu juglonă (variante)
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
FR2844197B1 (fr) * 2002-09-05 2006-06-23 Galderma Res & Dev Solution pour application ungueale et peri-ungeale
PT1545619E (pt) * 2002-09-05 2008-02-28 Galderma Sa Solução destinada a uma aplicação sobre as unhas
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US20050070501A1 (en) * 2003-09-29 2005-03-31 New York Blood Center, Inc. Water dispersible film
GB0401113D0 (en) * 2004-01-19 2004-02-18 Glaxo Group Ltd Tooth whitening composition
CA2617184A1 (en) * 2004-07-29 2006-02-02 Blonde Holdings Pty Ltd. A colour compensating system
US8586011B2 (en) * 2004-07-29 2013-11-19 Blonde Holdings Pty Ltd. Skin coating composition and uses thereof
CA2623565A1 (en) * 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
EP2457560A1 (en) * 2006-06-14 2012-05-30 Dr Reddy's Laboratories Limited Topical compositions
CA2671615A1 (en) * 2006-12-04 2008-06-12 Smithkline Beecham Corporation Topical pharmaceutical composition
WO2009070638A1 (en) * 2007-11-30 2009-06-04 Toltec Pharmaceuticals, Llc Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
EP2280690A2 (en) * 2008-04-18 2011-02-09 Nanobio Corporation Methods for treating herpes virus infections
US20100048598A1 (en) * 2008-08-21 2010-02-25 Sateesh Kandavilli Topical compositions comprising 5-alpha reductase inhibitors

Also Published As

Publication number Publication date
ES2751100T3 (es) 2020-03-30
RU2578959C2 (ru) 2016-03-27
BR112013033145A2 (pt) 2017-01-24
WO2012175879A1 (fr) 2012-12-27
US20140130711A1 (en) 2014-05-15
EP2723385A1 (fr) 2014-04-30
FR2976808B1 (fr) 2013-06-28
MX338724B (es) 2016-04-27
CN103796682A (zh) 2014-05-14
MX2013015200A (es) 2014-03-21
CA2839473C (fr) 2019-09-24
CN103796682B (zh) 2016-06-29
CA2839473A1 (fr) 2012-12-27
LT2723385T (lt) 2019-11-11
BR112013033145B1 (pt) 2021-01-12
RU2014101705A (ru) 2015-07-27
KR20140045963A (ko) 2014-04-17
EP2723385B1 (fr) 2019-07-31
AU2012273819A1 (en) 2014-01-16
ZA201309630B (en) 2015-04-29
FR2976808A1 (fr) 2012-12-28
KR101898635B1 (ko) 2018-09-13
US9226989B2 (en) 2016-01-05
PT2723385T (pt) 2019-10-30
JP2014517060A (ja) 2014-07-17

Similar Documents

Publication Publication Date Title
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
IL253870A0 (en) Certain amino-pyrimidines, their assemblies, and methods of using them
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
HUE056081T2 (hu) Vetõmag bevonatok, bevonat készítmények és eljárások ezek alkalmazására
IL222465A0 (en) Certain amino-pyridazines, compositions thereof, and methods for their use
PT2785800T (pt) Composição de revestimento marcada e método para autenticação da mesma
EP2830654B8 (en) Methods and compositions for treating inflammation
EP2912127A4 (en) COATINGS, COMPOSITIONS, COATED OBJECTS AND METHODS
PT2760899T (pt) Composição de revestimento e respetiva utilização
IL232217A (en) Derivatives of Azul, pharmaceutical preparations containing them and their use
PL2694538T3 (pl) Sposoby terapeutyczne i profilaktyczne, zastosowania i kompozycje zawierające aneksynę a5
PL2729008T3 (pl) Systemy, sposoby i formulacje do leczenia raka
PT2744840T (pt) Composição de revestimento e respetiva utilização
PL2938684T3 (pl) Kompozycje nawierzchniowe, podłoża powlekane oraz powiązane sposoby
ZA201305939B (en) Hair treatment composition
GB201114962D0 (en) Composition, process and product
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
EP2672952A1 (en) Hair treatment compositions
ZA201309630B (en) Film-forming composition, and use thereof for treating herpes
PT2793946T (pt) Composição tópica filmogénica e uso da mesma para tratar ou prevenir a onicofagia
WO2013003465A9 (en) Methods and compositions for treating skin
HK1192450A (en) Film-forming composition, and use thereof for treating herpes
PL2760899T3 (pl) Kompozycja powłokowa i jej zastosowanie
PL2744840T3 (pl) Kompozycja powlekająca i jej zastosowanie
PT3539540T (pt) Inibidor de sglt2 1-cloro-4-(beta-d-glucopiranos-1-il)-2-[4-((s)-tetra-hidrofurano-3-iloxi)-benzil]-benzeno em combinação com insulina para utilização num método para redução do risco de hipoglicemia